Skip to content

Clinical trials

Phase 4 Thrombocytopenia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 4 Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20141
20171
20181
20212
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Completed3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese PLA General Hospital1
First Affiliated Hospital Xi'an Jiaotong University1
Institute of Hematology & Blood Diseases Hospital, China1
Novartis Pharmaceuticals1
Peking Union Medical College Hospital1
Peking University First Hospital1
Shandong University1
The Third People's Hospital of Chengdu1
Third Affiliated Hospital, Sun Yat-Sen University1
Tongji Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia10
Purpura, Thrombocytopenic, Idiopathic2
Acute-On-Chronic Liver Failure1
Connective Tissue Diseases1
End Stage Liver Disease1
Hepatitis B1
Hepatitis B, Chronic1
Leukemia, Myeloid, Acute1
Liver Failure1
Myelodysplastic Syndromes1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.